Results 101 to 110 of about 3,522 (161)

The Oncolytic Activity of Myxoma Virus against Soft Tissue Sarcoma Is Mediated by the Overexpression of Ribonucleotide Reductase. [PDF]

Clin Med Insights Oncol, 2021
Woo Y, Warner SG, Geha R, Stanford MM, Decarolis P, Rahman MM, Singer S, McFadden G, Fong Y.   +8 more
europepmc   +1 more source

Myxoma virus lacking the host range determinant M062 stimulates cGAS-dependent type 1 interferon response and unique transcriptomic changes in human monocytes/macrophages. [PDF]

PLoS Pathog, 2022
Conrad SJ, Raza T, Peterson EA, Liem J, Connor R, Nounamo B, Cannon M, Liu J.   +7 more
europepmc   +1 more source

Oncolytic myxoma virus and engineering strategies for advanced cancer immunotherapy. [PDF]

iScience
Trujillo Yeriomenko AD, Isaeva AS, Idota EE, Zhivoderov SP, Yurkov SG, Malogolovkin AS.   +5 more
europepmc   +1 more source

Transplantation of autologous bone marrow pre-loaded ex vivo with oncolytic myxoma virus is efficacious against drug-resistant Vk*MYC mouse myeloma. [PDF]

Oncotarget, 2022
Villa NY, Rahman MM, Mamola J, Sharik ME, de Matos AL, Kilbourne J, Lowe K, Daggett-Vondras J, D'Isabella J, Goras E, Chesi M, Bergsagel PL, McFadden G.   +12 more
europepmc   +1 more source

RNA Helicase A/DHX9 Forms Unique Cytoplasmic Antiviral Granules That Restrict Oncolytic Myxoma Virus Replication in Human Cancer Cells. [PDF]

J Virol, 2021
Rahman MM, Gutierrez-Jensen AD, Glenn HL, Abrantes M, Moussatche N, McFadden G.   +5 more
europepmc   +1 more source

Testing Oncolytic Myxoma Virus in Immunocompetent Mouse Model for Cancer Therapy. [PDF]

Methods Mol Biol
Shakiba Y, Rahman MM.
europepmc   +1 more source

Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib. [PDF]

Oncolytic Virother, 2020
Ashton LV, Graham B, Afzali MF, Gustafson D, MacNeill AL.   +4 more
europepmc   +1 more source

Development of two indirect ELISAs using purified recombinant viral proteins to detect myxoma virus-antigen specific antibodies in rabbit sera. [PDF]

BMC Vet Res
Calonge-Sanz I, Casais R, Nicieza I, Vicente SA, Dos Santos FAA, Martín-Alonso JM, Domínguez P, Álvarez AL, Duarte MD, Parra F, Dalton KP.   +10 more
europepmc   +1 more source

NSCs are permissive to oncolytic Myxoma virus and provide a delivery method for targeted ovarian cancer therapy. [PDF]

Oncotarget, 2020
Cornejo Y, Li M, Dellinger TH, Mooney R, Rahman MM, McFadden G, Aboody KS, Hammad M.   +7 more
europepmc   +1 more source

Identification and Characterisation of a Myxoma Virus Detected in the Italian Hare (Lepus corsicanus). [PDF]

Viruses
Rossini E, Bazzucchi M, Trocchi V, Merzoni F, Bertasio C, Knauf S, Lavazza A, Cavadini P.   +7 more
europepmc   +1 more source